Houston, TXNCT07182279Now EnrollingIRB Ready

Prostate Cancer (Adenocarcinoma) Clinical Trial in Houston, TX

Access cutting-edge prostate cancer (adenocarcinoma) treatment through this clinical trial at a research site in Houston. Study-provided care at no cost to qualified participants.

Sponsored by The Methodist Hospital Research Institute

Quick Self-Assessment

See if you qualify for this Houston location

Preparing your pre-screening questions…

Expert Care in Houston

Access prostate cancer (adenocarcinoma) specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related prostate cancer (adenocarcinoma) treatment provided free

Apply for This Houston Location

Check if you qualify for this prostate cancer (adenocarcinoma) clinical trial in Houston, TX

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Houston

    Convenient for TX residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Houston site if eligible
  4. 4Begin participation

About This Prostate Cancer (Adenocarcinoma) Study in Houston

This is a Phase I/II trial evaluating the effectiveness of adding neoadjuvant HDR-B prior to RALP for HR-PCa patients with selective AAB for decipher high risk or pathologically node positive patients. Patients with newly diagnosed, histologically confirmed, non-metastatic, HR-PCa who are scheduled to receive RALP will be eligible to participate in the study.

Sponsor: The Methodist Hospital Research Institute

Who Can Participate

Inclusion Criteria

Subjects must have biopsy-confirmed adenocarcinoma of the prostate.
Subjects must have a negative bone scan and CT scan or PSMA-PET for nodal or metastatic disease.
Subjects must have one of the following risk factors:
PSA ≥20 and/or
Gleason score ≥8 and/or
Clinical or radiographic stage ≥T3a per AJCC (American Joint Committee on Cancer) 8th Edition Staging Manual and/or
At least two out of four of the following: PSA (Prostate Specific Antigen) 10-19.9, GS (Gleason Score) = 4+3, clinical stage = T2b/T2c, ≥50% positive biopsy cores.
Subjects must freely sign informed consent to enroll in the study.
Subjects must be medically fit to undergo surgery and HDR-B as determined by the PI.
ECOG Performance Status (performance status is an attempt to quantify cancer patients\' general well-being and activities of daily life, scores range from 0 to 5 where 0 represents perfect health and 5 represents death): 0-1.
No prior invasive malignancy in the past 3-years, except non-melanomatous skin cancer unless disease free for a minimum of 2 years. Carcinoma in-situ of the bladder or head and neck region is permissible.
Subjects must not have had prior androgen deprivation therapy in the past 6 months.

Exclusion Criteria

Metastatic disease as demonstrated by bone scan, CT scan, MRI of the pelvis, or PSMA-PET.
Declared high-risk for anesthesia by attending cardiologist, or other physician.
History of prior pelvic radiation therapy.
Prostate gland \>70 cc as assessed by MRI or TRUS.
Baseline IPSS \>15 with medical optimization.
History of androgen deprivation therapy within the past 6 months (except finasteride if discontinued \> 3 mo. prior to enrollment).
Unwilling or unable to comply with the study protocol. \-

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Houston?

Yes, this clinical trial (NCT07182279) has an active research site in Houston, TX that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Prostate Cancer (Adenocarcinoma) Treatment Options in Houston, TX

If you're searching for prostate cancer (adenocarcinoma) treatment options in Houston, TX, this clinical trial (NCT07182279) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Houston research site is actively enrolling participants for this clinical trial. You'll receive care from experienced prostate cancer (adenocarcinoma) specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all prostate cancer (adenocarcinoma) clinical trials near you to find additional studies recruiting in your area.

More Prostate Cancer Trials in Houston, TX

See all prostate cancer clinical trials recruiting in Houston — not just this study.

Browse Prostate Cancer Trials in Houston →

Browse More Trials by Condition

Prostate Cancer TrialsAlzheimers Disease TrialsAtopic Dermatitis TrialsAll Conditions →

Ready to Join in Houston?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Houston, TX